TABLE III.
Brain region | Dose of METH (mg/kg) | [3H| DPDPE binding (fmol/mg tissue) |
|
---|---|---|---|
Wild type | μ-OR knockout | ||
Striatum (Bregma: 1.58 mm) | 0 | 69.69 ± 0.93 | 60.64 ±0.65**** |
0.625 | 68.01 ± 1.64 | 63.37 ± 0.75* | |
2.5 | 73.18 ± 0.53*,** | 70.20 ± 0.30*,** | |
10 | 71.36 ± 0.63** | 74.95 ± 1.09*,**,*** | |
Nucleus accumbens (Bregma: 1.58 mm) | 0 | 73.55 ± 1.61 | 60.48 ± 0.91**** |
0.625 | 71.77 ± 1.97 | 63.69 ± 0.76* | |
2.5 | 76.62 ± 0.86** | 70.23 ± 0.76*,** | |
10 | 74.84 ± 0.89 | 74.63 ± 1.63*,**,*** |
Values arc presented as mean ± SEM (eight mice per group). Statistical analysis was performed by two-way ANOVA, followed by Student-Newman-Keuls test.
P < 0.05 compared with the respective saline-treated group.
P < 0.05 compared with the 0.625 mg/kg-treated groups.
P < 0.05 compared with the 2.5 mg/kg-treated group.
P < 0.05 compared with the corresponding wild-type mice.